The underlying cause of LCHADD retinopathy is not fully understood. This presentation will look at the research that identifies the cell in the eye that is initially affected and characteristics associated with vision loss. Dr. Gillingham will present early data on the natural history study and some new pre-clinical models to test novel treatments for LCHADD retinopathy.